PDF herunterladen
CC BY-NC-ND 4.0 · Journal of Social Health and Diabetes 2019; 7(02): 77-80
DOI: 10.1055/s-0039-1694300
Original Article

Understanding Clinical Inertia in Diabetes

Raveendran Arkiath Veettil 
1   Department of Medicine, Government Medical College, Manjeri, Kottayam, Kozhikode, Kerala, India
› Institutsangaben Funding None.
› Weitere Informationen
   Lizenzen und Reprints

Abstract

Clinical inertia is common in the management of asymptomatic chronic disease such as diabetes, hypertension, and dyslipidemia. In case of diabetes, it exists in all stages of management of diabetes. It can be at population level or at patient level. In addition to assessment of glycemic control with blood glucose and hemoglobin A1C (HbA1C) monitoring, emerging concepts such as “glycemic variability” and “time in range” are increasingly used. Inability to reduce “glycemic variability” and attain “time in range” targets also contributes to clinical inertia.

Keywords

clinical inertia - clinical inertia at patient care level - clinical inertia at population - diagnostic inertia - reverse clinical inertia - therapeutic inertia


Publikationsverlauf

Eingereicht: 10. Mai 2019

Angenommen: 18. Mai 2019

Artikel online veröffentlicht:
29. Juli 2019

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Phillips LS, Branch WT, Cook CB. et al. Clinical inertia. Ann Intern Med 2001; 135 (09) 825-834
    Google Scholar
  • 2 National Institute of Clinical Studies. Evidence-Practice Gaps Report. Vol. 1. Melbourne, Australia: NICS; 2003
    Google Scholar
  • 3 Byrnes PD. Why haven’t I changed that? Therapeutic inertia in general practice. Aust Fam Physician 2011; 40 (1-2) 24-28
    PubMedGoogle Scholar
  • 4 Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension 2006; 47 (03) 345-351
    CrossrefPubMedGoogle Scholar
  • 5 Gil-Guillén V, Orozco-Beltrán D, Pérez RP. et al. Clinical inertia in diagnosis and treatment of hypertension in primary care: quantification and associated factors. Blood Press 2010; 19 (01) 3-10
    PubMedGoogle Scholar
  • 6 Reach G. Patient non-adherence and healthcare-provider inertia are clinical myopia. Diabetes Metab 2008; 34 (4 Pt 1) 382-385
    CrossrefPubMedGoogle Scholar
  • 7 Rodrigo C, Amarasuriya M, Wickramasinghe S, Constantine GR. Therapeutic momentum: a concept opposite to therapeutic inertia. Int J Clin Pract 2013; 67 (01) 97-98
    PubMedGoogle Scholar
  • 8 Giugliano D, Maiorino MI, Bellastella G, Esposito K. Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes. J Endocrinol Invest 2019; 42 (05) 495-503 Review
    CrossrefPubMedGoogle Scholar
  • 9 Khunti K, Davies MJ. Clinical inertia-Time to reappraise the terminology?. Prim Care Diabetes 2017; 11 (02) 105-106
    CrossrefPubMedGoogle Scholar
  • 10 Mohan V. Expanding the concept of ‘clinical inertia’ in diabetes. J Diabetol 2019; 10: 1-3
    CrossrefGoogle Scholar
  • 11 O’Connor PJ, Sperl-Hillen JM, Johnson PE, Rush WA, Biltz G, Clinical inertia and outpatient medical errors. Agency for Healthcare Research and Quality. April 2005. Available at: http://www.ahrq.gov/downloads/pub/advances/vol2/OConnor.pdf. Accessed July 18, 2019.
  • 12 Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care 2004; 27 (07) 1535-1540
    CrossrefPubMedGoogle Scholar
  • 13 Unnikrishnan R, Mohan V. Why screening for type 2 diabetes is necessary even in poor resource settings. J Diabetes Complications 2015; 29 (07) 961-964
    CrossrefPubMedGoogle Scholar
  • 14 Satya Krishna SV, Kota SK, Modi KD. Glycemic variability: clinical implications. Indian J Endocrinol Metab 2013; 17 (04) 611-619
    CrossrefPubMedGoogle Scholar
  • 15 Lu J, Ma X, Zhou J. et al. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes. Diabetes Care 2018; 41 (11) 2370-2376
    CrossrefPubMedGoogle Scholar